Akebia Therapeutics Inc (AKBA)
1.37
0.00 (0.00%)
USD |
NASDAQ |
Apr 24, 16:00
1.37
0.00 (0.00%)
After-Hours: 19:58
Akebia Therapeutics Market Cap: 286.84M for April 24, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 23, 2024 | 286.84M |
| April 22, 2024 | 284.75M |
| April 19, 2024 | 284.75M |
| April 18, 2024 | 291.03M |
| April 17, 2024 | 291.03M |
| April 16, 2024 | 293.12M |
| April 15, 2024 | 291.03M |
| April 12, 2024 | 305.68M |
| April 11, 2024 | 320.34M |
| April 10, 2024 | 326.62M |
| April 09, 2024 | 322.43M |
| April 08, 2024 | 320.34M |
| April 05, 2024 | 311.96M |
| April 04, 2024 | 316.15M |
| April 03, 2024 | 311.96M |
| April 02, 2024 | 330.81M |
| April 01, 2024 | 341.28M |
| March 28, 2024 | 383.15M |
| March 27, 2024 | 468.99M |
| March 26, 2024 | 418.74M |
| March 25, 2024 | 462.71M |
| March 22, 2024 | 454.34M |
| March 21, 2024 | 427.12M |
| March 20, 2024 | 406.18M |
| March 19, 2024 | 383.15M |
| Date | Value |
|---|---|
| March 18, 2024 | 395.71M |
| March 15, 2024 | 355.93M |
| March 14, 2024 | 286.84M |
| March 13, 2024 | 295.21M |
| March 12, 2024 | 276.31M |
| March 11, 2024 | 280.20M |
| March 08, 2024 | 286.04M |
| March 07, 2024 | 284.09M |
| March 06, 2024 | 289.93M |
| March 05, 2024 | 311.33M |
| March 04, 2024 | 315.22M |
| March 01, 2024 | 332.74M |
| February 29, 2024 | 307.44M |
| February 28, 2024 | 299.66M |
| February 27, 2024 | 319.12M |
| February 26, 2024 | 293.82M |
| February 23, 2024 | 262.69M |
| February 22, 2024 | 270.47M |
| February 21, 2024 | 276.31M |
| February 20, 2024 | 280.20M |
| February 16, 2024 | 282.14M |
| February 15, 2024 | 286.04M |
| February 14, 2024 | 297.71M |
| February 13, 2024 | 295.77M |
| February 12, 2024 | 315.22M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
45.99M
Minimum
Nov 29 2022
1.944B
Maximum
Jun 30 2020
470.41M
Average
426.75M
Median
Market Cap Benchmarks
| Ocugen Inc | 301.07M |
| Aquestive Therapeutics Inc | 286.61M |
| SELLAS Life Sciences Group Inc | 86.37M |
| Protagonist Therapeutics Inc | 1.498B |
| Stoke Therapeutics Inc | 538.98M |
Market Cap Related Metrics
| PS Ratio | 1.319 |
| Price | 1.37 |
| Earnings Yield | -20.44% |